PROCEPT BioRobotics Corporation Common Stock (PRCT) — Analysis Summary
PROCEPT BioRobotics Corporation Common Stock (PRCT) has a market cap of $1.40B with year-over-year revenue growth of +64.8%. Net margin stands at -40.7%. The stock trades at a P/E ratio of -15.3.
Key Takeaways
- Revenue changed +64.8% year-over-year
- Net margin of -40.7%
- P/E ratio of -15.3
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, PRCT posted revenue growth of +64.8% and trades at a P/E of -15.3.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.